{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:11:15Z","timestamp":1791983475417,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The vast majority of epithelial ovarian cancer arises from tissues that are embryologically derived from the M\u00fcllerian Duct. Here, we demonstrate that a DNA methylation signature in easy-to-access M\u00fcllerian Duct-derived cervical cells from women with and without ovarian cancer (i.e. referred to as the Women\u2019s risk IDentification for Ovarian Cancer index or WID-OC-index) is capable of identifying women with an ovarian cancer in the absence of tumour DNA with an AUC of 0.76 and women with an endometrial cancer with an AUC of 0.81. This and the observation that the cervical cell WID-OC-index mimics the epigenetic program of those cells at risk of becoming cancerous in <jats:italic>BRCA1\/2<\/jats:italic> germline mutation carriers (i.e. mammary epithelium, fallopian tube fimbriae, prostate) further suggest that the epigenetic misprogramming of cervical cells is an indicator for cancer predisposition. This concept has the potential to advance the field of risk-stratified cancer screening and prevention.<\/jats:p>","DOI":"10.1038\/s41467-021-26615-y","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:03:16Z","timestamp":1643734996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The DNA methylome of cervical cells can predict the presence of ovarian cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"James E.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-498X","authenticated-orcid":false,"given":"Chiara","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kantaraja","family":"Chindera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-5535","authenticated-orcid":false,"given":"Olivia C.","family":"Leavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Zikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-9356","authenticated-orcid":false,"given":"David","family":"Cibula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Widschwendter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"26615_CR1","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson, G. C., Kohn, E. C., Kitchener, H. C. & Ledermann, J. A. Ovarian cancer. Lancet 384, 1376\u20131388 (2014).","journal-title":"Lancet"},{"key":"26615_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/aje\/kww091","volume":"184","author":"MA Clyde","year":"2016","unstructured":"Clyde, M. A. et al. Risk prediction for epithelial ovarian cancer in 11 United States-based case-control studies: incorporation of epidemiologic risk factors and 17 confirmed genetic loci. Am. J. Epidemiol. 184, 579\u2013589 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"26615_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/jmedgenet-2018-105313","volume":"55","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. J. Med. Genet. 55, 546\u2013554 (2018).","journal-title":"J. Med. Genet."},{"key":"26615_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","volume":"24","author":"CL Pearce","year":"2015","unstructured":"Pearce, C. L. et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol. Biomark. Prev. 24, 671\u2013676 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"26615_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103077","volume":"52","author":"S Jervis","year":"2015","unstructured":"Jervis, S. et al. A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. J. Med. Genet. 52, 465\u2013475 (2015).","journal-title":"J. Med. Genet."},{"key":"26615_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs, I. J. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387, 945\u2013956 (2016).","journal-title":"Lancet"},{"key":"26615_CR7","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1200\/JCO.2016.69.9330","volume":"35","author":"AN Rosenthal","year":"2017","unstructured":"Rosenthal, A. N. et al. Evidence of stage shift in women diagnosed with ovarian cancer during Phase II of the United Kingdom familial ovarian cancer screening study. J. Clin. Oncol. 35, 1411\u20131420 (2017).","journal-title":"J. Clin. Oncol."},{"key":"26615_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann, L. C. & Lindor, N. M. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N. Engl. J. Med. 374, 454\u2013468 (2016).","journal-title":"N. Engl. J. Med."},{"key":"26615_CR9","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci. Transl. Med. 10, eaap8793 (2018).","DOI":"10.1126\/scitranslmed.aap8793"},{"key":"26615_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/path.5314","volume":"249","author":"V Lac","year":"2019","unstructured":"Lac, V. et al. Oncogenic mutations in histologically normal endometrium: the new normal? J. Pathol. 249, 173\u2013181 (2019).","journal-title":"J. Pathol."},{"key":"26615_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.celrep.2019.05.109","volume":"28","author":"JJ Salk","year":"2019","unstructured":"Salk, J. J. et al. Ultra-sensitive TP53 sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan. Cell Rep. 28, 132\u2013144 e3 (2019).","journal-title":"Cell Rep."},{"key":"26615_CR12","doi-asserted-by":"publisher","first-page":"e1002206","DOI":"10.1371\/journal.pmed.1002206","volume":"13","author":"N Nair","year":"2016","unstructured":"Nair, N. et al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study. PLoS Med. 13, e1002206 (2016).","journal-title":"PLoS Med."},{"key":"26615_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","volume":"580","author":"L Moore","year":"2020","unstructured":"Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Nature 580, 640\u2013646 (2020).","journal-title":"Nature"},{"key":"26615_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11620","volume":"7","author":"TE Bartlett","year":"2016","unstructured":"Bartlett, T. E. et al. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat. Commun. 7, 11620 (2016).","journal-title":"Nat. Commun."},{"key":"26615_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78\u201385 (2000).","journal-title":"N. Engl. J. Med."},{"key":"26615_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-7-8","volume":"7","author":"DC Koestler","year":"2014","unstructured":"Koestler, D. C. et al. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. BMC Med. Genomics 7, 8 (2014).","journal-title":"BMC Med. Genomics"},{"key":"26615_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/gepi.21815","volume":"38","author":"SJ Winham","year":"2014","unstructured":"Winham, S. J. et al. Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. Genet. Epidemiol. 38, 457\u2013466 (2014).","journal-title":"Genet. Epidemiol."},{"key":"26615_CR18","unstructured":"Yang, Y. et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Res. (2018)."},{"key":"26615_CR19","doi-asserted-by":"crossref","unstructured":"Widschwendter, M. et al. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat. Rev. Clin. Oncol. 15, 292\u2013309 (2018).","DOI":"10.1038\/nrclinonc.2018.30"},{"key":"26615_CR20","doi-asserted-by":"publisher","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","volume":"24","author":"L Dubeau","year":"2013","unstructured":"Dubeau, L. & Drapkin, R. Coming into focus: the nonovarian origins of ovarian cancer. Ann. Oncol. 24, viii28\u2013viii35 (2013).","journal-title":"Ann. Oncol."},{"key":"26615_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).","journal-title":"Genome Biol."},{"key":"26615_CR22","doi-asserted-by":"publisher","first-page":"e8274","DOI":"10.1371\/journal.pone.0008274","volume":"4","author":"AE Teschendorff","year":"2009","unstructured":"Teschendorff, A. E. et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS ONE 4, e8274 (2009).","journal-title":"PLoS ONE"},{"key":"26615_CR23","doi-asserted-by":"crossref","unstructured":"Zheng, S. C. et al. A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics 10, 925\u2013940 (2018).","DOI":"10.2217\/epi-2018-0037"},{"key":"26615_CR24","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann, L. C. & Lindor, N. M. Risk-reducing surgery in hereditary breast and ovarian cancer. N. Engl. J. Med. 374, 2404 (2016).","journal-title":"N. Engl. J. Med."},{"key":"26615_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0500-7","volume":"9","author":"M Widschwendter","year":"2017","unstructured":"Widschwendter, M. et al. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer. Genome Med. 9, 116 (2017).","journal-title":"Genome Med."},{"key":"26615_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jmoldx.2015.11.004","volume":"18","author":"G Margolin","year":"2016","unstructured":"Margolin, G. et al. Robust detection of DNA hypermethylation of ZNF154 as a Pan-cancer locus with in silico modeling for blood-based diagnostic development. J. Mol. Diagn. 18, 283\u2013298 (2016).","journal-title":"J. Mol. Diagn."},{"key":"26615_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gepi.22269","volume":"44","author":"V Kilaru","year":"2020","unstructured":"Kilaru, V. et al. Critical evaluation of copy number variant calling methods using DNA methylation. Genet. Epidemiol. 44, 148\u2013158 (2020).","journal-title":"Genet. Epidemiol."},{"key":"26615_CR28","doi-asserted-by":"publisher","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","volume":"46","author":"CA Davis","year":"2018","unstructured":"Davis, C. A. et al. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 46, D794\u2013D801 (2018).","journal-title":"Nucleic Acids Res."},{"key":"26615_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","volume":"571","author":"P Jonsson","year":"2019","unstructured":"Jonsson, P. et al. Tumour lineage shapes BRCA-mediated phenotypes. Nature 571, 576\u2013579 (2019).","journal-title":"Nature"},{"key":"26615_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nm1230","volume":"11","author":"W Cheng","year":"2005","unstructured":"Cheng, W., Liu, J., Yoshida, H., Rosen, D. & Naora, H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat. Med. 11, 531\u2013537 (2005).","journal-title":"Nat. Med."},{"key":"26615_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1158\/1055-9965.EPI-11-0009","volume":"20","author":"L Mellemkjaer","year":"2011","unstructured":"Mellemkjaer, L. et al. Risk of primary non-breast cancer after female breast cancer by age at diagnosis. Cancer Epidemiol. Biomark. Prev. 20, 1784\u20131792 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"26615_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1006\/meth.2001.1268","volume":"25","author":"BN Trinh","year":"2001","unstructured":"Trinh, B. N., Long, T. I. & Laird, P. W. DNA methylation analysis by MethyLight technology. Methods 25, 456\u2013462 (2001).","journal-title":"Methods"},{"key":"26615_CR33","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22 (2017).","journal-title":"Nucleic Acids Res"},{"key":"26615_CR34","unstructured":"Hovestadt, V. & Zapatka, M. Conumee: Enhanced copy-number variation analysis using Illumina DNA methylation arrays. R package version 1.9.0, http:\/\/bioconductor.org\/packages\/conumee\/."},{"key":"26615_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"26615_CR36","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"26615_CR37","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"26615_CR38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","volume":"49","author":"CM Phelan","year":"2017","unstructured":"Phelan, C. M. et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat. Genet. 49, 680\u2013691 (2017).","journal-title":"Nat. Genet."},{"key":"26615_CR39","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005\u2013D1012 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26615-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:53:56Z","timestamp":1669305236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26615-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26615"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26615-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.M. received an honorarium for grant review from the Israel National Institute for Health Policy Research and from MSD, Astra Zeneca, and GSK for advisory board meetings. UCLB (UCL\u2019s commercialisation company) has filed a patent on some aspects described in the paper\u2014M.W. and J.E.B. are named as inventors on this patent. J.E.B., C.H., and M.W. are shareholders of Sola Diagnostics GmbH, which holds an exclusive licence to the intellectual property that protects the commercialisation of the WID-OC test. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}